Funding for this research was provided by:
Icahn School of Medicine at Mount Sinai
Received: 18 August 2020
Accepted: 14 January 2021
First Online: 5 February 2021
Ethics approval and consent to participate
: The Bio<i>Me</i> Biobank is an ongoing research biorepository approved by the Icahn School of Medicine at Mount Sinai’s IRB (protocol number 07-0529). The Icahn School of Medicine at Mount Sinai’s IRB approved the pre-pilot survey study (protocol number 15-00440), including a waiver of informed consent and a HIPAA waiver of authorization. This research conformed to the Declaration of Helsinki.
: Not applicable
: N.S.A-H. was previously employed by Regeneron Pharmaceuticals and has received a speaker honorarium from Genentech. E.E.K. has received speaker honoraria from Illumina and Regeneron Pharmaceuticals. The remaining authors declare no competing interests.